Experiment 338958

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)ISOLATION AND IDENTIFICATION OFTOXICITY MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

ELAIOMYCIN

Details

PropertyValue
Pharmacology
CARCINOGENIC ACTIVITY
Administration routeIP
OrganismStreptomyces hepaticus (STREPTOMYCETACEAE)
CitationSCHOENTAL,R:. (1972). TOXICITY AND CARCINOGENIC ACTION IN RATS OF ELAIOMYCIN A METABOLITE OF STREPTOMYCES HEPATICUS.. 2()
Amount utilized
Compound isolated
DiseaseLIVER TUMORS RESEMBLING THOSE INDUCED BY CYCASIN STOMACH TUMORS(GASTRIC) KIDNEY,BRAIN,THYMUS AND LYMPH GLAND TUMORS SMALL INTESTINE TUMORS EXOCRINE PANCREAS TUMORS
Dose amount40.0 MG
Number1
Qualitative resultACTIVE
AnimalRAT
Per unitKG
Dose expressionDOSE